Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice

Cancer Research

Volumn 60, Issue 4, 2000, Pages 808-814

  Smith, Shirley I ^a   Down, Michelle ^a   Boyd, Andrew W ^a,b   Li, Chung L ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ACUTE LEUKEMIA; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; LEUKEMIA CELL; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MOUSE; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TUMOR SUPPRESSOR GENE;

ANIMALS; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA, EXPERIMENTAL; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; WT1 PROTEINS;

EID: 0034652714     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hastie, N. D. The genetics of Wilms' tumor-a case of disrupted development. Annu. Rev. Genet., 28: 523-558, 1994.
2. Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M., and Housman, D. E. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl. Acad. Sci. USA, 88: 9618-9622, 1991.
3. Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard. J., Buckler, A., Pelletier, J., Housman, D., van Heyningen, V., and Hastie, N. The candidate Wilms' tumour gene is involved in genitourinary development. Nature (Lond.), 346: 194-197, 1990.
4. Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. WT-1 is required for early kidney development. Cell, 74: 679-691, 1993.
5. Little, M., and Wells, C. A clinical overview of WT1 gene mutations. Hum. Mutat., 9: 209-225, 1997.
6. Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., Tatekawa, T., Soma, T., Kishimoto, T., and Sugiyama, H. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood, 89: 1405-1412, 1997.
7. Miwa, H., Beran, M., and Saunders, G. F. Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia (Baltimore), 6: 405-409, 1992.
8. King-Underwood, L., Renshaw, J., and Pritchard-Jones, K. Mutations in the Wilms' tumor gene WT1 in leukemias. Blood, 87: 2171-2179, 1996.
9. King-Underwood, L., and Pritchard Jones, K. Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood, 91: 2961-2968, 1998.
10. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., Nasu, K., Kyo, T., Dohy, H., Nakauchi, H., Ishidate, T., Akiyama, T., and Kishimoto, T. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood, 84: 3071-3079, 1994.
11. Haber, D. A., Park, S., Maheswaran, S., Englert, C., Re, G. G., Hazen Martin, D. J., Sens, D. A., and Garvin, A. J. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science (Washington DC), 262: 2057-2059, 1993.
12. McMaster, M. L., Gessler, M., Stanbridge, E. J., and Weissman, B. E. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line. Cell Growth Differ., 6: 1609-1617, 1995.
13. Menke, A. L., Riteco, N., van Ham, R. C., de Bruyne, C., Rauscher, F. J., III, van der Eb, A. J., and Jochemsen, A. G. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby rat kidney cells. Oncogene, 12: 537-546, 1996.
14. Ichikawa, Y. Differentiation of a cell line of myeloid leukemia. J. Cell. Physiol., 74: 223-234, 1969.
15. Honma, Y., Kasukabe, T., and Hozumi, M. Relationship between leukemogenicity and in vivo inducibility of normal differentiation in mouse myeloid leukemia cells. J. Natl. Cancer Inst., 61: 837-841, 1978.
16. Ichikawa, Y. Further studies on the differentiation of a cell line of myeloid leukemia. J. Cell. Physiol., 76: 175-184, 1970.
17. Honma, Y., Kasukabe, T., Okabe, J., and Hozumi, M. Prolongation of survival time of mice inoculated with myeloid leukemia cells by inducers of normal differentiation. Cancer Res., 19: 3167-3171, 1979.
18. Smith, S. I., Weil, D., Johnson, G. R., Boyd, A. W., and Li, C. L. Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells. Blood, 91: 764-773, 1998.
19. Ikeda, K., Monden, T., Kanoh, T., Tsujie, M., Izawa, H., Haba, A., Ohnishi, T., Sekimoto, M., Tomita, N., Shiozaki, H., and Monden, M. Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections. J. Histochem. Cytochem., 46: 397-403, 1998.
20. Mies, C., Houldsworth, J., and Chaganti, R. S. Extraction of DNA from paraffin blocks for Southern blot analysis. Am. J. Surg. Pathol., 15: 169-174, 1991.
21. Svedberg, H., Chylicki, K., Baldetorp, B., Rauscher, F. J. R., and Gullberg, U. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program. Oncogene, 16: 925-932, 1998.
22. Deuel, T. F., Guan, L. S., and Wang, Z. Y. Wilms' tumor gene produce WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain. Biochem. Biophys. Res. Commun., 254: 192-196, 1999.
23. Luo, X. N., Reddy, J. C. Yeyati, P. L., Idris, A. H., Hosono, S., Haber, D. A., Licht, J. D., and Atweh, G. F. The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene, 11: 743-750, 1995.
24. Menke, A. L., van der Eb, A. J., and Jochemsen, A. G. The Wilms' tumor 1 gene: oncogene or tumor suppressor gene? Int. Rev. Cytol., 181: 151-212, 1998.
25. Phelan, S. A., Lindberg, C., and Call, K. M. Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ., 5: 677-686, 1994.
26. Sekiya, M., Adachi, M., Hinoda, Y., Imai, K., and Yachi, A. Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells. Blood, 83: 1876-1882, 1994.
27. Algar, E. M., Khromykh, T., Smith, S. I., Blackburn, D. M., Bryson, G. J., and Smith, P. J. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene, 12: 1005-1014, 1996.
28. Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, T., Hirata, M., Kudoh, T., Akiyama, T., Murakami, A., and Maekawa, T. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood, 87: 2878-2884, 1996.
29. Murata, Y., Kudoh, T., Sugiyama, H., Toyoshima, K., and Akiyama, T. The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Lett., 409: 41-45, 1997.